There has been a substantial increase in research activity on autism during the past decade. Research into effective ways of responding to the immediate needs of autistic people is, however, less advanced, as are efforts at translating basic science research into service provision. Involving community members in research is one potential way of reducing this gap. This study therefore investigated the views of community involvement in autism research both from the perspectives of autism researchers and of community members, including autistic adults, family members and practitioners. Results from a large-scale questionnaire study (n = 1,516) showed that researchers perceive themselves to be engaged with the autism community but that community members, most notably autistic people and their families, did not share this view. Focus groups/interviews with 72 participants further identified the potential benefits and remaining challenges to involvement in research, especially regarding the distinct perspectives of different stakeholders. Researchers were skeptical about the possibilities of dramatically increasing community engagement, while community members themselves spoke about the challenges to fully understanding and influencing the research process. We suggest that the lack of a shared approach to community engagement in UK autism research represents a key roadblock to translational endeavors.
Citation: Pellicano E, Dinsmore A, Charman T (2014) Views on Researcher-Community Engagement in Autism Research in the United Kingdom: A Mixed-Methods Study. PLoS ONE 9(10): e109946. https://doi.org/10.1371/journal.pone.0109946
Editor: Sassy Molyneux, University of Oxford, Kenya
Received: December 3, 2013; Accepted: September 13, 2014; Published: October 10, 2014
Copyright: © 2014 Pellicano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Inge Wakehurst Foundation, the Charles Wolfson Foundation, and The Waterloo Foundation. The funders had no role in the design of the study, collection and analysis of the data, or preparation and review of the manuscript.
Competing interests: Dr. Charman has received grant or research support from the UK Medical Research Council, European Commission FP7, European Science Foundation, Autism Speaks, the Simons Foundation, Autistica, Research Autism, and the Waterloo Foundation. He has received royalties from Guilford Press and Sage. Dr Pellicano has received grant or research support from the Medical Research Council, the Australian Research Council, the Nuffield Foundation, Research Autism, and the Waterloo Foundation. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Basic scientific research is fundamental to improving human health. Yet the application of major scientific breakthroughs to where they are most needed, in clinics and communities, is often not swiftly forthcoming . Translational research has therefore become a high priority for biomedical research policy around the world. Research centres have been established, grant programmes launched and scientists have been urged to think anew about the potential impact of their research. These initiatives have been motivated to accelerate “the translation of discoveries from basic laboratory and clinical science into benefits for human health  and to ensure public accountability for the investment in basic science. But whatever the precise driver, the core intention of translational research is clear: to close the gap between fundamental biomedical research and clinical, educational and related practice –.
The potential benefits of translational research are nowhere greater than in the field of autism. There has been a dramatic increase in the recorded prevalence of autism in the past few decades –. Recent figures estimate that approximately 1% of the population in the United Kingdom has an autism spectrum condition –, with similar estimates recorded in other parts of the world . There has also been a dramatic expansion of research, particularly on neural and cognitive systems, genetics and other causal pathways both in the UK and abroad –. This surge in basic autism science promises to enhance the life chances of autistic people and their families. Yet the translational potential of this work remains unfulfilled, partly because only a minority of UK research funding is directed towards identifying effective treatments, interventions and services for individuals with autism . As a result, the opportunities and life-chances for autistic people remain often severely limited in comparison with the non-autistic population. It has thus become imperative for autism researchers to reduce the translational gap.
In biomedical research more broadly, models of translational research have moved beyond a unidirectional bench-to-bedside approach to ones that also encourage backwards translation, with knowledge “from the bedside” informing research in the laboratory . There is growing recognition, however, that even these bi-directional approaches can be overly simplistic; that the translational process is instead multidirectional and dynamic, including multiple points of knowledge exchange not only between researcher and practitioner communities but also, critically, between researcher and “patient” communities. That appears to be rarely the case in practice, however. Despite good intentions, in many current models  engagement of stakeholders is usually restricted to the dissemination and implementation phases – the very ends of the “translational pipeline”. Yet it is plausibly argued that translation will only be successful when scientific discoveries are more thoroughly relevant to “patients” and communities, are sufficiently tailored to the realities of their everyday lives and are consistent with their values –.
In response, there has been a deliberate expansion of public participation across the UK's National Health Service (www.invo.org.uk), where health and social care researchers are encouraged to involve “patients” and members of the public as partners in the research process – working actively with community members rather than on or for them . Such community engagement might be thought to be particularly important with regard to autism, given the long history of controversial claims by autism scientists – from “refrigerator mothers”  to the vaccine furore  – and the growing distrust of mainstream autism science by autistic self-advocates –. This entails that efforts to engage the broader autism community have advantages beyond any practical use they may or may not have in directly translating research findings into concrete changes in clinical and other practice. Engagement can potentially help overcome distrust between professionals and others, can strengthen the self-esteem and self-respect of researched communities and can help ensure that the research process properly responds to the interests and entitlements of autistic people –.
Despite the potential importance of such efforts, almost nothing is formally known about the extent to which the autism community is engaged in research, beyond being involved as ‘subjects’. We simply do not know how commonplace formal or informal engagement practices are in autism research and whether a lack of community engagement represents a barrier to the translational endeavour. This study aimed to address these issues by asking both researchers and members of the autism community about their experiences of engagement in research. The autism community, however, is not homogenous and seldom speaks with a singular voice . We therefore also examined potential differences in the degree and nature of the engagement experiences of distinct groups within the autism community. Rather than the more commonly used terms such as “patients”, “service user” or “stakeholder”, we use the term “autism community” to reflect the varied nature of this group, which includes those who are autistic themselves and those who care for, or who work with, children, young people and adults on the autism spectrum.
Focus groups and interviews
Seventy-two participants took part in 11 focus groups and 10 individual interviews, including 14 autistic adults (2 female), 27 parents of autistic children (all mothers), 20 practitioners (18 female; 2 speech and language therapists; 16 teachers, 2 educational psychologists), 11 autism researchers (5 female; 6 early career researchers). Of the mothers, their children ranged in age from 5 to 19 years and also ranged in ability from those who had limited spoken language (n = 10) to those who they considered to be cognitively able or “high functioning” (n = 27). These groups were selected because they each held a “stake” in autism research. Autistic adults, parents and practitioners were recruited through community contacts across the UK. Researchers were recruited through personal contacts.
The focus groups and semi-structured interviews followed the same format. Discussion focused on participants' perceptions of current UK autism research and their priorities for future research (analysis of these data are presented in ). Towards the end of these discussions, we elicited participants' views and perspectives about the degree and nature of the autism community's engagement in research. Specifically, we asked about their experiences of being involved in research (or, in the case of researchers, involving the autism community in their research) and how they would like to be involved in the future.
Each focus group was kept exclusive (e.g., autistic adults only) and was conducted face-to-face in a location convenient for participants. Groups were led by a facilitator, who from time-to-time summarised the key points to the group and confirmed the interpretation of comments. Focus groups ranged from 44 to 124 mins (M = 93 mins). Interviews were conducted either face-to-face (n = 4), over Skype (n = 2) or on the telephone (n = 4), and lasted between 32 and 104 mins (M = 51 mins).
Where possible, focus groups/interviews were audiotaped and subsequently transcribed and analysed using the NVivo software package (Version 9). The resulting data were analysed using thematic analysis . We adopted an inductive approach, providing descriptive overviews of the key features of the semantic content of data within an essentialist framework. Two of the authors (LP and AD) independently familiarised themselves with the data, meeting regularly to discuss preliminary themes and make a list of provisional codes. Each author then independently applied an exhaustive list of codes to the transcript of each interview/focus group. The authors met several times to review the results, resolve discrepancies and decide how the codes could be collapsed into themes and subthemes. All authors approached the coding and discussions from the perspective of autism scientists with an interest in public and community engagement in research.
To reach a larger sample of the UK's autism community, we then developed an online questionnaire to gauge people's experiences of autism research in the UK. To encourage participation, this questionnaire was brief (11 questions), following a very similar structure to the focus groups/interviews. The design of the questionnaire was informed by the results of the focus groups/interviews, yielding changes to specific wording of items and the inclusion of the category ‘dissemination’ in our levels of engagement question (see below). This latter modification was in response to parents' wide-ranging experiences of hearing about autism research being conducted in the UK.
The questionnaire began with a series of background items (UK resident, primary interest in autism research, age, gender) followed by questions relating to participants' research priorities and their perspectives on the pattern of UK funding for autism research . The final three questions related to the degree of engagement in research between the autism/research communities. Specifically, we asked participants (1) to indicate how often they had experienced three levels of ‘engagement’ (public dissemination, dialogue and partnership) between autism researchers and the broader autism community (on a 5-point scale from ‘very rarely’ (score of 1) to ‘very frequently’ (score of 5)), (2) to rate how satisfied they were with the level of engagement they had experienced (on a 5-point scale from ‘very dissatisfied’ (score of 1) to ‘very satisfied’ (score of 5)), and (3) to provide a reason for their stated level of satisfaction (open comment).
Respondents were told that engagement between researchers and the broader autism community could occur in a variety of ways including through:
- Dissemination, where researchers provide information about the results of completed research through newsletters, online blogs, public events, etc.
- Dialogue, where researchers communicate directly or consult with members of the autism community for their views about the research being conducted.
- Partnership, where researchers and members of the autism community collaborate, as partners, in the research process, working together to set research goals and coming up with ways of realising them.
Our three levels of engagement differed somewhat from those advocated by INVOLVE (which include (1) consultation, (2) collaboration, and (3) lay control; see www.invo.org.uk and ) because (a) our initial results from the focus groups suggested that several community members had no previous experience of engaging in autism research (see below) and (b) instances of user-controlled autism research are extremely rare. Our levels of engagement therefore might be conceived of as lower down the rungs of a ‘ladder of participation’  than those of INVOLVE but nevertheless reflected the current range of engagement activities in this particular field of research.
Participants were recruited through extensive community canvassing, including through autistic organisations, parent advocacy groups, practitioner and researcher networks, and via social media (Twitter, Facebook) and online fora. 1,632 people completed the engagement items of the questionnaire. To facilitate comparisons with the focus groups/interviews, analysis focused upon the 1,516 respondents aged 18 and over who could be divided into four key stakeholder groups: autistic adults, immediate family members, practitioners and researchers (see Table 1). The remaining 107 participants, who had labeled themselves as ‘other’ (e.g., student, “interested in autism”), were not considered further. For parents and carers (n = 825), the mean age of their child with autism was 13.4 years (SD = 9.0; range = 2–57; 142 females) and, for sons, daughters or siblings (n = 24), the mean age of their autistic family member was 27.1 years (SD = 16.3; range = 4–65; 6 females).
To ensure that our study was accessible as possible, autistic adults were invited to take part in the study using a range of formats (focus group, individual face-to-face interview, telephone/Skype interview and email); both the questions for discussion and the survey questions were offered to autistic participants so that they could review them in advance, if required; and two autistic adults acted as pilot participants and worked with the research team to make sure that discussion and survey items were comprehensible and easy to respond to.
Focus groups/interviews: Researcher views
Uncertainty towards community involvement.
The first subtheme related to the limits of involvement (see Figure 1A). For some researchers there was a strong sense of the need for real participation in research: “we have to involve them from the very start, in helping to define and shape the research”. Others felt that people making judgments about research and research funding “have to be other scientists” but that the viewpoints of different stakeholders should nevertheless be consulted: “I don't think that we want it to, the decision making, to move away from the scientists but I think they should at least get input from relevant stakeholders”. Others still were wary about involving autistic people and their families in decisions about research because (a) they might not be the appropriate people to decide what and how issues should be researched and (b) it risks “politicizing” scientific issues.
The second subtheme was contesting partnership. While there was consensus that involving members of the autism community as partners in research was not commonplace in autism research, researchers nevertheless differed in what they meant by “partnership”. Some researchers understood it as members of the autism community being involved in priority-setting exercises, while others talked of such members “contributing feedback” and “being on steering groups”. There were also suggestions that the nature and degree of involvement depended on the type of research being conducted: “People are much more likely to be better at involvement or engagement with people when there's a very direct patient interaction … whereas if you're dealing with anonymized urine samples or DNA samples then you're less likely to directly try and engage with stakeholders.”
The final subtheme related to the obstacles to, but potential rewards of, community engagement. Some researchers acknowledged the potential costs of community involvement, including the considerable time, money and effort spent in building and maintaining partnerships. Researchers were also concerned about the diversity of views within the autism community and the unlikelihood of any disputes being resolved. Others noted the potential benefits to involvement, including increased awareness of the research process by autistic people, families and practitioners and “a better chance that the research will get translated into practice”.
Focus groups/interviews: Community views
The majority of autistic adults, parents of children with autism and professionals wanted to be more involved in the research process. The two themes identified related to their deeply variable experiences of involvement and the consequences of lack of involvement (see Figure 1B).
Deeply variable experiences of involvement.
The nature of participants' experience of involvement in research varied widely but, overall, community members felt that researchers aren't proactive enough. Some parents, particularly those whose children had limited spoken communication, commented that they had never been approached by researchers to be part of research: “So I just find it really weird that, as a parent, you aren't approached about doing research, or providing information, that kind of thing, you have to go out and find it yourself.” These parents were perplexed that researchers were not “utilizing families” who were “waiting to be tapped into”. Practitioners noted the challenges of parental involvement, however, due to the busy nature of their lives: “it is often difficult to round up [parents] and get them involved”.
Parents and autistic adults with some experience of research emphasized the largely asymmetric interactions with researchers. Parents in particular highlighted that they “never get to find out the outcome.” One mother said, “I get a lot of asking for help. And then a bit less [contact] when something's going on, and hardly any results!” They wanted their involvement as participants to be valued by researchers. Autistic adults' reports were more negative, noting “sometimes we are a bit like monkeys in a zoo.” They spoke of the lack of reciprocity in their interactions with researchers: “they only want us as guinea pigs; that's the only contact they want with us.”
Autistic adults and parents also reported not feeling valued by researchers. Some participants were genuinely unaware that they could have a say in research while others were skeptical of the possibility of actually influencing research: “It's like not anybody is interested” (parent); “Whatever we say, is that really going to influence anyone?” (autistic adult). Some autistic adults reported that even when they had a voice, it was not listened to: “I just think sometimes when we say something we just sort of throw a spanner in the works, it doesn't suit their sort of agenda.” Others noted experiences of paternalism: “That's the danger of when someone knows you have a diagnosis, because there suddenly seems to be some sort of ascendency process that goes on and suddenly they have the right then to talk down to you, because you've got a label.” These adults stressed the need for researchers to value their expertise (of being autistic: “You have your area of expertise, which is not mine, and we have our area of expertise; you have to look at us on a similar level”) and for their involvement in research to extend beyond mere tokenism. Instead, they wanted to see more autistic people involved in research projects because “a lot of things aren't done with the autistic subjective kind of values and wants in mind.”
Practitioners were more positive about building links with researchers than autistic adults and family members. They highlighted the important links being built between researchers and their schools or clinics: “It's good that the people on the ground are trying to help support academia to come up with questions that are actually pertinent to what we want to find out about.”
Consequences of lack of involvement in research.
Parents and autistic adults who had been involved as participants in research generally felt that research findings were indigestible. They emphasized their interest in research but also noted that they “haven't got the time to read lots of information, absorb it, react to it, go and search for something that links to it” (parent). Many commented that the information they received was not written in a “user-friendly” way, being full of scientific jargon: “when I read stuff that neurotypicals write about autism, for me it just reads like gobbledygook, it just doesn't make any sense” (autistic adult). They suggested that research findings “need to be simplified for them to understand what researchers are actually trying to put across” and needed to be targeted specifically at them, “coming through my door”, rather than having to have to find it themselves.
Parents and practitioners spoke of the disconnect between the research that goes on and that research that would actually make a difference to their lives or the lives of those they work with: “Researchers are not interested in social issues or anything like that, all they are interested is in medical issues” (parent). Parents reported feeling “jaded” and “cynical” about “pointless” research that is so far removed from their everyday experiences of autism. One mother said, “I fill in all these questionnaires and do everything I can to help and there's a very nice paper at the end with nice results and it's like “great”. But when it comes down to it, it's not real life. It's always missing the next step – great you've done this research, you've listened to my views, you've asked for them I've given them, but now do something with it.” Other parents felt as if the people making the decisions about research have probably “never been anywhere near someone with autism.” One mother said, “I think [contact with autistic people] would benefit the researchers, because they are kind of getting first hand experience from the people that are living with the children with autism … that I think would help towards the research because it's giving them an idea of what's really happening every single day.”
Some parents also felt frustrated with the lack of certainty that research provides; that there were no clear-cut answers or not enough research on the topics about which they needed answers. Their observations suggested that the lack of community involvement potentially resulted in a limited understanding of the research process: “I found as well that a lot of the researchers kind of contradict themselves, like one researcher will stand up and sort of say if your child goes on this gluten free diet it will better them, and improve this etc., and then you hear another researcher say no, that's rubbish, absolute rubbish.”
Autistic adults specifically spoke of their expertise (of being autistic) and the benefits that an insider autistic view would bring to research. They felt that the lack of community involvement in research led to differences in interpretation: “I feel that whoever's doing research is coming from a certain perspective, and you are starting off with an assumption that that person's disabled, and then you are looking at the research on the basis that we are disabled, like a rat in a cage, and if you do research like that you are probably going to end up very far, you know, confirming your own suspicions at the beginning.” One autistic adult suggested that, “having more autistic researchers or employing people on teams might guard against the possibility of misinterpretation [of findings].”
Online questionnaire: Frequency ratings
Descriptive statistics for respondents' frequency ratings of engagement are shown in Table 2. With regards to dissemination, autistic adults, family members and practitioners reported that they had experienced dissemination of research ‘occasionally’ (mode score of ‘3’), while researchers reported ‘frequently’ (mode score of ‘4’) participating in dissemination with the broader autism community. With respect to dialogue, autistic adults and practitioners indicated that they ‘occasionally’ experienced dialogue with researchers but family members said that they ‘very rarely’ (mode score of ‘1’) experienced this sort of engagement. Researchers felt, however, that they ‘frequently’ participated in a dialogue with members of the autism community. All of the community groups stated that they had ‘very rarely’ (mode score of ‘1’) experienced partnership with researchers while researchers felt that they were ‘occasionally’ (mode score of ‘3’) involved in partnerships with autism community members.
One-way ANOVAs on participants' mean ratings (see Table 2) with group as a factor (autistic adults, family members, practitioners, researchers) revealed significant group differences for dissemination, F(3, 1,515) = 22.69, p<.001, dialogue, F(3, 1,515) = 58.65, p<.001, and partnership, F(3, 1,515) = 33.28, p<.001. Post-hoc tests (Tukey's HSD) revealed the source of these differences. Note that because of the relatively large number of comparisons conducted, results are not reported as significant unless they reached a p value of less than .01.
Overall, researchers reported being engaged in dissemination, dialogue and partnership significantly more frequently than autistic adults, family members and practitioners reported experiencing such engagement (all ps<.01). There were also some subtle differences between community members' ratings. Autistic adults and family members reported being less involved in dissemination than practitioners (both ps<.005). Family members' mean ratings were significantly lower for dialogue than both autistic adults and practitioners (both ps<.005) but the latter two groups did not differ (p = .95). Finally, family members' ratings of the frequency with which they experienced partnerships with researchers were significantly lower (i.e., less frequent) than practitioners (p<.001) but not autistic adults (p = .22). Autistic adults' and practitioners' ratings did not differ (p = .64).
We then examined the degree to which researchers and non-researchers were satisfied with this level of engagement. A one-way ANOVA on the mean ratings confirmed that the distribution of responses were slightly skewed towards ‘dissatisfied’ for autistic adults and family members but less so for practitioners and researchers (see Figure 2). There was a main effect of group, F(3, 1,515) = 14.16, p<.001. Researchers' (M = 3.02; SD = 1.01) and practitioners' (M = 2.96; SD = .90) ratings were significantly higher (reflecting greater satisfaction) than both autistic adults (M = 2.60; SD = 1.26) and family members (M = 2.63; SD = .97) (both ps<.005). There were no other group differences (ps>.90).
Open question: Researcher views
Survey respondents were also asked to specify their reasons for their level of satisfaction with engagement in research (852 responses). Of the 63 researchers who responded to this question (see Table 3 for themes and corresponding quotes), several noted the importance of involving the autism community in the research process: “The perspectives of the population being researched should always be the first starting point.” All other comments centred on the invitation to engage and the barriers to engagement (see Table 3). Several researchers expressed how receptive and supportive the broader autism community had generally been to hearing about, or requests to take part in, research. Others' experiences were less positive, however, noting that involvement often amounted to a “tick-box exercise”. With regards to the potential barriers of involvement, some researchers pointed to a lack of a singular voice within the autism community, while others noted that the communication difficulties experienced by autistic people posed considerable problems for wider involvement in research.
Open question: Community views
Comments from community members focused on similar themes, including their experiences of engagement in research and barriers to engagement (see Table 4). With regards to members' experiences of involvement, a common subtheme was the lack of awareness of the research being conducted. All three groups reported receiving few approaches from researchers to participate actively in research and there was uncertainty surrounding how they might come to know about such opportunities. Of those that had participated in research, many community members linked their level of satisfaction with engagement to researchers' attitudes. Respectful attitudes among researchers were often cited for high levels of satisfaction, although community members' experiences were not always so positive, with some highlighting a lack of interest in autistic adults' or practitioners' experience and expertise. Other dissatisfied community members focused on the nature of the often one-sided interactions with researchers. They reported being frustrated with the little or no feedback provided by researchers following participation.
The second theme again centred on barriers to engagement in research. For autistic adults and parents, these barriers included their own or their autistic relative's age, gender, and level of functioning; research often excluded adults, especially older adults, girls and women, and those with additional (and severe) intellectual disabilities. Parents also cited the prohibitive time demands of caring for their child with autism and practitioners spoke of difficulties finding the time for involvement in research in their already busy lives. Finally, for some respondents, their experiences of involvement had led to some scepticism about research. Many autistic respondents credited their lack of satisfaction to what they described as “dehumanizing” interactions (“being treated like guinea pigs”) and the predominance of a neurotypical outlook (i.e., one focused on cure and prevention of autism) among researchers.
Some autistic adults, parents and practitioners felt that they had limited access to research and its findings, and were especially critical of the prevalence of prohibitive paywalls and journal subscription requirements. Both parents and practitioners were critical of the language used in research reports, which made it inaccessible to lay audiences, and which caused them to feel “swamped” and “bombarded” with information they did not understand. Community members also commented on researchers' priorities for autism research, which seemed to conflict with their own. They were more likely to feel satisfied by their level of engagement in research if the projects in which they participated had explicit, practical applications. Some members, especially parents and practitioners, reported feeling “let down” by research that had no bearing on their everyday lives.
Within traditional models of research, researchers design and implement their studies, and interpret and disseminate the findings, only seeking interaction with the community during the recruitment and participation stages. Yet the need to speed up the translation of basic science findings into practical applications has prompted calls for greater participation in the research process by communities across health-related research  (www.invo.org.uk). This study is the first to investigate the degree and nature of community involvement in the field of autism research both from the perspectives of researchers and of members of the autism community. We sought to understand current engagement practices and identify potential barriers and opportunities to engagement in research and, ultimately, to the translational endeavour.
There were competing views between stakeholder groups regarding the degree of engagement in current UK autism research. Overall, researchers perceived themselves to be engaged with the autism community – in terms of the extent to which they disseminated their findings, consulted the autism community and developed partnerships with its members – but other stakeholders, most notably autistic people and their families, did not share this view to the same degree. Practitioners were more likely to have engaged with researchers either through dialogue or through the building of research-practice networks and were generally satisfied with this degree of engagement. Given that models of translational research have traditionally emphasised knowledge exchange between researchers and practitioners, this finding is perhaps not surprising. Autistic adults and particularly family members were less satisfied with their involvement, however, which ranged widely from non-participation to acting as consultants in research. It is true, of course, that these results may not be representative of the entire autism community – particularly those who cannot communicate well enough to advocate for themselves – but the fact that the findings from the online questionnaire mirrored the findings in the focus groups/interviews give us reason to believe this dissatisfaction is widely shared.
This relative lack of satisfaction by certain community members might be driven by unrealistic expectations of research, in which progress can be frustratingly slow, and for parents in particular, anxieties about the need for “quick fixes” and help in the here-and-now. The challenges surrounding the communication of results and the realities of research to the public are not specific to autism research, but occur across science and humanities . The core skill set of researchers – including experimental design, statistical analysis and communication of results to academic peers – does not involve mechanisms of outreach, especially with potentially vulnerable groups. This issue might well be a problem with researcher training or a lack of clear guidelines  but will nevertheless take some time to change.
Beyond better science communication, there were also conflicting views about the nature and extent of involvement in autism research by researchers themselves. Individual researchers had very different conceptions of what engagement in research does – and should – look like. Some researchers felt strongly that the autism community should be more involved in research, largely in identifying research priorities, which would increase participation and external validity. Others, however, were apprehensive about such involvement, perceiving it as a potential threat to scientific (internal) validity. Notably, all of our researcher respondents implicitly viewed the autism community as relatively passive in the research process, rather than actively involved in knowledge production. Indeed, no researcher suggested that community members should be co-producers of research, that is, that the balance of power with regards to key scientific decision-making processes (priority-setting, funding decisions, design, implementation, interpretation or dissemination) should be equal between researchers and members of the autism community, as it is in community-based participatory models of research –, and none mentioned the possibility of user-controlled research (www.invo.org.uk).
This (implicit) resistance to engaging the autism community may be related to the largely negative descriptions of autistic adults' and family members' interactions with researchers. Family members felt disappointed and frustrated at being ‘mined’ for information and having little or no opportunity to learn about the resulting discoveries and what they might mean for them, while autistic adults reported feeling objectified (“we are a bit like monkeys in a zoo”) and their experiential expertise disregarded by researchers. This lack of reciprocity resulted in feelings of distrust and being less motivated to participate in future research.
This pattern is not unique to autism research. Other studies examining researchers' attitudes to user involvement in health research also report feelings of apprehension, particularly with regard to challenges to traditional knowledge production and acquisition –. Scientific research prizes itself for being impartial, falsifiable and rigorous. For some, the very involvement of those with a vested interest (e.g., patients) potentially introduces bias or reduces objectivity, and is thus seen as less valid and reliable.
Not only does this argument imply that researchers are bias-free (which is not the case; –), it also suggests that the only people permitted to make decisions about research are researchers themselves. Moreover, in some, possibly many, cases, the benefits of community involvement outweigh the (putative) risks. Community involvement in research theoretically increases the likelihood that research findings will be implemented in communities because their involvement ensures that (i) research findings and interventions are accessible, useful and sustainable, (ii) research addresses issues of real-life practical import, and (iii) services and interventions are tailored to fit the community's needs , . Without such involvement, the research findings are at risk of being ‘lost in translation’.
Contemporary models of patient involvement have built upon Arnstein's “ladder of citizen participation”  in which the rungs of the ladder reflect increasing levels of participation and degree of citizen control in decision making ranging from non-participation or manipulation and therapy through to tokenism, including informing, consulting and placating, and to the higher rungs of citizen power via partnership, delegated power and citizen control. Current policy initiatives, including the UK's Department of Health INVOLVE initiative (www.invo.org.uk), aim to move patient involvement in research “further up the ladder”, increasing the degree of involvement – and decision-making power – in the research process. Critics have suggested that the higher rungs of the ladder may not be easily attainable in research because research is often researcher-led . There is, however, a strong literature of successful participatory or emancipatory research with people with intellectual and learning disabilities – and there are rare exceptions in US autism research , , providing proof that partnership in research is at least sometimes possible and can be achieved in such a way as to accommodate the fact that the autism community is both diverse in its needs and is geographically widely dispersed. The current findings suggest, however, that the degree of community involvement in UK autism research remains close to the bottom of the ladder.
This lack of involvement in autism research might be one reason for the apparent mismatch between what is currently being researched in the UK and what community members want from such research. A recent survey of the state of current autism research in the UK found that the majority of funded research between 2007 and 2011 focused upon understanding the underlying biology and causes of autism (i.e., basic science) . When consulted about the UK's research profile, there was overwhelming consensus from community members that the imbalance in current research must be addressed, with greater priority on research that has an immediate, practical impact on people's everyday lives . Autistic people, their family members and practitioners are rarely actively engaged in the research process – in deciding how an issue is researched, how it becomes funded, who undertakes the research and so on. Developing ways to involve the autism community both in priority-setting exercises in specific areas and in the research process more broadly is one way to ensure that a greater portion of research has a direct and sustained impact on those who need it most.
How, then, can we support greater community involvement in research? There is no ‘one size fits all’ approach to community engagement. It will necessarily vary according to the research aims, the project, the target participants, the individual researcher(s) and so on. The process should therefore both be experimental and iterative. Researchers should be encouraged to innovate in a variety of ways as they develop more widespread mechanisms of engagement between researchers and the autism community, doing so in ways that seem suitable to the particular circumstances and which reflect continuing discussions and debates concerning the right way to represent autistic people and other community members. Researchers need to develop mutually supportive and respectful relationships with members of the autism community – relationships that are both intrinsically valuable and necessary for the transfer of research findings into practice –.
Developing these research-community partnerships takes time, effort and often funding. Indeed, our researcher participants mentioned a lack of supportive infrastructures as a real barrier to community engagement. Others ,  have highlighted many challenges, including lack of time, energy, and resources to build and sustain partnerships, limited funding mechanisms and institutional commitment, and lack of researcher training, especially regarding power-sharing arrangements, raising questions regarding whether such intensive community engagement is suitable for all research. Some of our participants suggested that the degree of engagement in research might differ depending on the area of research. While it is true that basic or laboratory-based scientists might be less likely to interact with, and thus engage, the autism community, or to perceive benefits from such engagement, this distance should not be a rationale for limiting engagement. Many aspects of genetic and biomarker research – the hallmarks of translational research – conducted in basic science laboratories carry complex social and ethical implications related to “risk” (of developing autism) and cure and prevention , . These very issues are the ones that often provoke the most unease within the autism community and extra efforts must be taken to ensure that autistic people and their families are involved, not excluded, from basic science research . Engaging with UK community members should be the first step in determining how and to what extent they might shape the research process.
Grant-giving bodies and government agencies should work towards developing supportive infrastructure, actively encouraging researcher-community dialogues at all stages of the translational process, and providing the necessary training. Some research should aim to involve partnerships between researchers and community members, which should be genuinely participatory and not just tokenistic, where autistic people and other key stakeholders are ‘co-producers’ of the research. Building such institutional mechanisms of engagement requires sustained effort. There are ways, however, in which researchers can act now to develop mutually supportive partnerships with the autism community. Researchers should actively promote their research, ensuring that it reaches community members in an accessible (i.e., jargon-free) manner. They should also listen to the views and perspectives of the autism community to understand – and value – what it is like to be autistic, to care for someone who is autistic, or to work with someone who is autistic – valuing their expertise and thus reducing the epistemological divide . Similarly, the autism community should work towards increasing their ‘research literacy’, gaining a better understanding of research and the challenges involved.
While the call for greater community involvement in research is not new , the current findings suggest that autism researchers have not readily embraced it. The lack of commitment to involving the community in research potentially presents a significant challenge for successful translational autism research. Ensuring that the advances in research impact upon those who need them most requires sustained engagement with the community at all stages of the translation process, however difficult that may seem – from establishing the research priorities and conducting the research, to disseminating and implementing the final products/intervention – while at the same time maintaining scientific rigor. Building and maintaining mutually supportive partnerships is one viable way of achieving this goal . As these partnerships unfold, researchers will need to explore in detail people's experiences of them and, ultimately, to determine their impact.
We thank Deepa Korea, Richard Mills and Helen Finch at Research Autism, Erica Salomone and Mark Taylor for help during the focus groups, Dan Sinclair for production of figures and Marc Stears for helpful discussion on a previous version of the manuscript. We are also extremely grateful to all those who took part in all aspects of the research, including the questionnaire, focus groups and interviews.
Conceived and designed the experiments: EP TC AD. Performed the experiments: EP TC AD. Analyzed the data: EP TC AD. Wrote the paper: EP TC.
- 1. Ioannidis JPA (2004) Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med 2: 5
Medical Research Council (2008) Research changes lives: Strategic Plan 2009–2014. London, MRC. Available: http://www.mrc.ac.uk/research/strategy/. Accessed 2014 June 2.
Cooksey D (2006) A Review of UK Health Research Funding. London: Stationery Office 2006.
- 4. Insel TR (2009) Translating scientific opportunity into public health impact: A strategic plan for research on mental illness. Arch Gen Psychiatry 66: 128–133.
- 5. Zerhouni E (2003) The NIH Roadmap. Science 302: 63–72.
- 6. Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65: 591–598.
- 7. Gernsbacher MA, Dawson M, Goldsmith HH (2005) Three reasons not to believe in an autism epidemic. Curr Dir Psychol Sci 14: 55–58.
- 8. Baird G, Simonoff E, Pickles A, Chandler S, Lucas T, et al. (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368: 210–215.
- 9. Brugha TS, McManus S, Bankart J, Scott F, Purdon S, et al. (2011) Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 68: 459–65.
- 10. Elsabbagh M, Divan G, Koh Y, Kim YS, Kauchali S, et al. (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5: 160–179.
- 11. Dawson G (2013) Dramatic increase in autism prevalence parallels explosion of research into its biology and causes. Arch Gen Psychiatry 70: 9–10.
Office of Autism Research Coordination, National Institute of Mental Health, on behalf of the Interagency Autism Coordinating Committee (IACC) (2010) IACC Autism Spectrum Disorder Research Portfolio Analysis Report 2012. Available: www.iacc.hhs.gov/portfolio-analysis/2010/index.shtml.
Pellicano E, Dinsmore A, Charman T (2013) A Future Made Together: Shaping Autism Research in the UK. London: Institute of Education.
- 14. Callard F, Rose D, Wykes T (2012) Close to the bench as well as at the bedside: Involving service users in all phases of translational research. Health Expect 15: 389–400.
- 15. Chalmers I (2004) Well informed uncertainties about the effects of treatments: How should clinicians and patients respond? BMJ 328: 475–476.
- 16. Lloyd K, White J (2011) Democratizing clinical research. Nature 474: 277–278.
- 17. Partridge N, Scadding J (2004) The James Lind Alliance: Patients and clinicians should jointly identify their priorities for clinical trials. Lancet 364: 1923–1924.
- 18. van der Laan AL, Boenink M (2012) Beyond bench and bedside: Disentangling the concept of translational research. Health Care Anal 20: 84–102.
National Institute for Health Research (2012) INVOLVE Strategy 2012–2015: Putting people first in research. National Institute for Health Research. Available: http://www.invo.org.uk/wp-content/uploads/2012/04/INVOLVEStrategy2012-15.pdf. Accessed 2013 July 15.
Bettelheim B (1967) The Empty Fortress: Infantile Autism and the Birth of the Self. New York: The Free Press.
- 21. Gross L (2009) A broken trust: Lessons from the vaccine-autism wars. PLoS Biol 7: e1000114.
- 22. Bagatell N (2010) From cure to community: Transforming notions of autism. Ethos 38: 33–55.
Dawson M (2004) The misbehavior of behaviourists. Available: http://www.sentex.net/~nexus23/naa_aba.html. Accessed 2013 Aug 2.
Sinclair J (1993) Don't mourn for us. First published in the Autism Network International newsletter, Our Voice, 1 1993. Available: http://www.jimsinclair.org/dontmourn.htm. Accessed 2010 Aug 5.
- 25. Pellicano E, Stears M (2011) Bridging autism, science and society: Moving towards an ethically-informed approach to autism research. Autism Res 4: 271–282.
- 26. Pellicano E, Ne'eman A, Stears M (2011) Engaging, not excluding: A reply to Walsh et al. Nat Rev Neurosci 12: 769.
- 27. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qualitative Research in Psychology 3: 77–101.
- 28. Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, et al. (2004) Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess 8: 1–148.
- 29. Arnstein S (1969) A ladder of citizen participation. Journal of the American Institute of Planners 35: 216–224.
Lambert R (2003) Lambert Review of Business-University Collaboration: Final Report. Her Majesty's Stationery Office 2003. Available: http://www.hm-treasury.gov.uk/media//EA556/lambert_review_final_450.pdf. Accessed 2013 July 15.
- 31. Hanley B, Truesdale A, King A, Elbourne D, Chalmers I (2001) Involving consumers in designing, conducting, and interpreting randomized controlled trials: questionnaire survey. BMJ 222: 519–523.
- 32. Ahmed S, Palermo A (2010) Community engagement in research: Frameworks for education and peer review. Am J Public Health 100: 1380–1387.
- 33. Nicolaidis C, Raymaker D, McDonald K, Dern S, Ashkenazy E, et al. (2011) Collaboration strategies in nontraditional community-based participatory research partnerships: Lessons from an academic-community partnership with autistic self-advocates. Progress in Community Health Partnerships: Research, Education, and Action 5: 143–150
- 34. Thompson J, Ward P, Barber R, Boote JD, Cooper CL, et al. (2009) Health researchers' attitudes towards public involvement in health research. Health Expect 12: 209–220.
- 35. Ward PR, Thompson J, Barber R, Armitage CJ, Boote JD, et al. (2010) Critical perspectives on ‘consumer involvement’ in health research: epistemological dissonance and the know-do gap. J Sociol 46: 63–82.
Moore K (2008) Disrupting Science: Social Movements, American Scientists, and the Politics of the Military, 1945–1975. Princeton, NJ: Princeton University Press.
- 37. Pashler H, Wagenmakers EJ (2012) Editors' introduction to the special section on replicability in psychological science: A crisis of confidence? Perspectives Psychol Sci 7: 528.
- 38. Faridi Z, Grunbaum JA, Sajor Gray B, Franks A, Simoes E (2007) Community-based participatory research: Next steps. Preventing Chronic Disease 4: 1–5.
- 39. Tritter JQ, McCallum A (2006) The snakes and ladders of user involvement: Moving beyond Arnstein. Health Policy 76: 156–168.
- 40. Nicolaidis C, Raymaker D, McDonald K, Dern S, Boisclair C, et al. (2013) Comparison of healthcare experiences in autistic and non-autistic adults: A cross-sectional online survey facilitated by an academic-community partnership. J Gen Intern Med 28: 761–769.
- 41. Ham M, Jones N, Mansell I, Northway R, Price L, et al. (2004) ‘I'm a researcher!’ Working together to gain ethical approval for a participatory research study. J Learn Disabil 8: 397–407.
- 42. Powers LE, Garner T, Valnes B, Squire P, Turner A, et al. (2007) Building a successful adult life: Findings from youth-directed research. Exceptionality: A Special Education Journal 15: 45–56.
- 43. Ward KM, Trigler JS (2001) Reflections on participatory action research with people with developmental disabilities. Mental Retardation 39: 57–59.
Pellicano E, Dinsmore A, Charman T (2014) What should autism research focus upon? Community views and priorities from the UK. Autism: doi: 10.1177/1362361314529627
- 45. Jones L, Wells K (2007) Strategies for academic and clinician engagement in community-participatory partnered research. JAMA 297: 407–410.
- 46. Tinetti ME, Basch E (2013) Patients' responsibility to participate in decision making and research. JAMA 309: 2331–2332.
- 47. Yudell M, Tabor HK, Dawson G, Rossi J, Newschaffer C (2013) Priorities for autism spectrum disorders: risk communication and ethics. Autism 17: 701–722.
- 48. Goodare H, Lockwood S (1999) Involving patients in clinical research. BMJ 319: 724–725.
- 49. Israel BA, Parker EA, Rowe Z, Salvatore A, Minkler M, et al. (2005) Community-based participatory research: Lessons learned from the centers for children's environmental health and disease prevention research. Environ Health Perspect 113: 1463–1471.
Sinclair J (1999) Why I dislike “person first” language. Available: http://www.cafemom.com/journals/read/436505/. Accessed 2013 Jan 19.